UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003645
Receipt number R000004410
Scientific Title Phase II study of CDDP/Alimuta combined with bevacizumab in patients with advanced non-small-cell lung cancer without harboring sensitive EGFR mutations
Date of disclosure of the study information 2011/01/01
Last modified on 2020/05/27 10:51:00

No. Disposal Last modified on Item of update
1 Insert 2010/05/20 17:40:23
2 Update 2013/05/20 09:22:44 Institute
Institute
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2016/05/20 19:15:42 Recruitment status
4 Update 2020/05/27 10:51:00 Recruitment status
Date of IRB